95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.49%
Revenue growth under 50% of FNV's 48.78%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.48%
Gross profit growth under 50% of FNV's 50.10%. Michael Burry would be concerned about a severe competitive disadvantage.
0.13%
EBIT growth below 50% of FNV's 84.85%. Michael Burry would suspect deeper competitive or cost structure issues.
0.13%
Operating income growth under 50% of FNV's 100.84%. Michael Burry would be concerned about deeper cost or sales issues.
-16.66%
Negative net income growth while FNV stands at 89.89%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-23.08%
Negative EPS growth while FNV is at 65.84%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while FNV is at 65.84%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.21%
Share reduction more than 1.5x FNV's 9.98%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.66%
Reduced diluted shares while FNV is at 9.96%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
8.47%
OCF growth under 50% of FNV's 189.34%. Michael Burry might suspect questionable revenue recognition or rising costs.
8.47%
FCF growth under 50% of FNV's 192.34%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
180.75%
10Y CAGR of 180.75% while FNV is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
89.12%
5Y CAGR of 89.12% while FNV is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
92.51%
3Y CAGR of 92.51% while FNV is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
629.21%
OCF/share CAGR of 629.21% while FNV is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
189.53%
3Y OCF/share CAGR of 189.53% while FNV is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
No Data
No Data available this quarter, please select a different quarter.
475.60%
Net income/share CAGR of 475.60% while FNV is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
158.49%
3Y net income/share CAGR of 158.49% while FNV is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
1024.24%
Equity/share CAGR of 1024.24% while FNV is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
261.75%
Equity/share CAGR of 261.75% while FNV is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.98%
Firm’s AR is declining while FNV shows 23.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
9.52%
Asset growth above 1.5x FNV's 0.75%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.14%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
27.56%
Debt growth of 27.56% while FNV is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-9.92%
We cut SG&A while FNV invests at 38.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.